Ostrum Asset Management Royalty Pharma PLC Transaction History
Ostrum Asset Management
- $2.13 Trillion
- Q2 2025
A detailed history of Ostrum Asset Management transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ostrum Asset Management holds 69,692 shares of RPRX stock, worth $2.52 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
69,692
Previous 61,850
12.68%
Holding current value
$2.52 Million
Previous $1.93 Billion
30.42%
% of portfolio
0.12%
Previous 0.1%
Shares
9 transactions
Others Institutions Holding RPRX
# of Institutions
495Shares Held
306MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.68 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.31 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$831 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$790 Million0.14% of portfolio
-
Baillie Gifford & CO18MShares$651 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...